Abstract 11146: AZD3366-an Optimized Recombinant Human Apyrase Combining Anti Platelet, Anti Inflammatory and Tissue Protective Actions With Low Bleeding Risk for Potential Mitigation of Thromboembolic Complications

Susanne Pehrsson,Bengt Kull,Daniel Hovdal,Marie Elebring,Carl Whatling,Ola Fjellström,Leif Carlsson

Abstract 11146: AZD3366-an Optimized Recombinant Human Apyrase Combining Anti Platelet, Anti Inflammatory and Tissue Protective Actions With Low Bleeding Risk for Potential Mitigation of Thromboembolic Complications

2019

Susanne Pehrsson
Bengt Kull
Daniel Hovdal
Marie Elebring
Carl Whatling
Ola Fjellström
Leif Carlsson

Antithrombotic therapies reduce cardiovascular events after acute myocardial infarction but are associated with increased bleeding. AZD3366 (APT102) is an engineered, optimized version of recombina...

Keywords:

Myocardial infarction
Pharmacology
Cardiology
Anti-inflammatory
Apyrase
Diabetes mellitus
Recombinant DNA
Thrombosis
Medicine
Internal medicine
Adenosine
Antithrombotic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations